Warning Letter Issued to Zimmer CAS

On 5/31/16, Zimmer Biomet (ZBH) received an FDA Warning Letter regarding observed non-conformities at the company’s Zimmer CAS/ORTHOsoft facility in Montreal, Quebec, Canada.

The letter relates to a Form 483 issued following an FDA facility inspection performed in January 2016.

The warning letter does not restrict production or shipment of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us